Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study

被引:16
作者
Kim, Hyung-Jun [1 ]
Lee, Jong Hyuk [2 ]
Yoon, Soon Ho [2 ]
Kim, Sung A. [1 ]
Kim, Myoung Sil [1 ]
Choi, Sun Mi [1 ]
Lee, Jinwoo [1 ]
Lee, Chang-Noon [1 ]
Han, Sung Koo [1 ]
Yim, Jae-Joon [1 ]
机构
[1] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea
关键词
Clinical medicine; Cohort studies; Diagnosis; Nontuberculous mycobacteria; Progression; LUNG-DISEASE; INDUCED SPUTUM; EPIDEMIOLOGY; AVIUM; ABSCESSUS; IDENTIFICATION; TUBERCULOSIS; PROGRESSION;
D O I
10.1186/s12879-019-4078-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundMicrobiological criteria for diagnosing nontuberculous mycobacterial pulmonary disease (NTM-PD) include positive culture results from at least two separately expectorated sputum specimens or one bronchial washing or lavage. However, the clinical similarities and differences between patients diagnosed by these two methods remain unclear. We compared clinical features and prognoses of patients with NTM-PD diagnosed from both specimen types.MethodsWe analysed data from patients who participated in the Seoul National University Hospital NTM-PD cohort (ClinicalTrials.gov identifier: NCT01616745). Baseline demographics, symptoms, radiographic findings, disease progression, and treatment responses were summarized and compared between patients diagnosed from sputum specimens and patients diagnosed from bronchoscopic specimens.ResultsThree hundred forty-seven patients were included in the analyses. Of these, 279 (80.4%) were diagnosed from two separately expectorated sputum specimens, and 68 (19.6%) were diagnosed from bronchoscopic specimens. Patients diagnosed from sputum specimens had more frequent and severe cough, sputum, postnasal drip, and high St. George's Respiratory Questionnaire scores. However, the extent and severity of the radiographic lesions, disease progression, and treatment responses were similar for both groups. Further analysis based on the following three groups (sputum culture positive, sputum culture negative/bronchoscopy, and scanty sputum/bronchoscopy groups) suggested that the scanty sputum/bronchoscopy group appeared to have the worst prognosis in terms of both time to progression and time to culture conversion.ConclusionsAlthough some symptoms and quality of life were worse in patients with NTM-PD diagnosed from sputum specimens, their prognoses were similar to those of patients diagnosed by bronchoscopic specimen. We recommend bronchoscopic sampling for patients in whom NTM-PD is suspected clinically or radiographically, especially those who have no or scanty sputum.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs
    Prevots, D. Rebecca
    Loddenkemper, Robert
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (04)
  • [42] Respiratory Review of 2014: Tuberculosis and Nontuberculous Mycobacterial Pulmonary Disease
    Park, Cheol Kyu
    Kwon, Yong Soo
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (04) : 161 - 166
  • [43] Pharmacotherapy for nontuberculous mycobacterial pulmonary disease
    Velagapudi, Manasa
    Sanley, Michael J.
    Ased, Sumaya
    Destache, Chris
    Malesker, Mark A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (06) : 437 - 445
  • [44] Bronchoscopy for the diagnosis of nontuberculous mycobacterial pulmonary disease: Specificity and diagnostic yield in a retrospective cohort study
    Tomishima, Yutaka
    Urayama, Kevin Y.
    Kitamura, Atsushi
    Okafuji, Kohei
    Jinta, Torahiko
    Nishimura, Naoki
    Tamura, Tomohide
    RESPIRATORY INVESTIGATION, 2022, 60 (03) : 355 - 363
  • [45] Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan
    Wang, Ping
    Morimoto, Kozo
    Hasegawa, Naoki
    Hassan, Mariam
    Chatterjee, Anjan
    ERJ OPEN RESEARCH, 2024, 10 (04)
  • [46] Nontuberculous Mycobacterial Pulmonary Disease: A Clinical and Radiologic Update
    Nguyen, Ivy
    Green, ONeil
    Modahl, Lucy
    SEMINARS IN ROENTGENOLOGY, 2022, 57 (01) : 75 - 89
  • [47] Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan
    Izumi, Kiyohiko
    Morimoto, Kozo
    Hasegawa, Naoki
    Uchimura, Kazuhiro
    Kawatsu, Lisa
    Ato, Manabu
    Mitarai, Satoshi
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (03) : 341 - 347
  • [48] Impact of body mass index on development of nontuberculous mycobacterial pulmonary disease
    Song, Jin Hwa
    Seong, Bong
    Kwak, Nakwon
    Han, Kyungdo
    Yim, Jae-Joon
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (02)
  • [49] Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease
    Phoompoung, Pakpoom
    Chayakulkeeree, Methee
    JOURNAL OF FUNGI, 2020, 6 (04) : 1 - 10
  • [50] Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease
    Abate, Getahun
    Stapleton, Jack T.
    Rouphael, Nadine
    Creech, Buddy
    Stout, Jason E.
    El Sahly, Hana M.
    Jackson, Lisa
    Leyva, Francisco J.
    Tomashek, Kay M.
    Tibbals, Melinda
    Watson, Nora
    Miller, Aaron
    Charbek, Edward
    Siegner, Joan
    Sokol-Anderson, Marcia
    Nayak, Ravi
    Dahlberg, Greta
    Winokur, Pat
    Alaaeddine, Ghina
    Beydoun, Nour
    Sokolow, Katherine
    Kown, Naomi Prashad
    Phillips, Shanda
    Baker, Arthur W.
    Turner, Nicholas
    Walter, Emmanuel
    Guy, Elizabeth
    Frey, Sharon
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (07) : 1127 - 1137